Les actions de Monopar Therapeutics ont reculé de 6,8 % lors de la séance de vendredi, après que Raymond James a abaissé sa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback